207 related articles for article (PubMed ID: 9693933)
1. Chromogranin A: its clinical value as marker of neuroendocrine tumours.
Nobels FR; Kwekkeboom DJ; Bouillon R; Lamberts SW
Eur J Clin Invest; 1998 Jun; 28(6):431-40. PubMed ID: 9693933
[TBL] [Abstract][Full Text] [Related]
2. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones.
Nobels FR; Kwekkeboom DJ; Coopmans W; Schoenmakers CH; Lindemans J; De Herder WW; Krenning EP; Bouillon R; Lamberts SW
J Clin Endocrinol Metab; 1997 Aug; 82(8):2622-8. PubMed ID: 9253344
[TBL] [Abstract][Full Text] [Related]
3. Circulating chromogranin A in the assessment of patients with neuroendocrine tumours. A single institution experience.
Stivanello M; Berruti A; Torta M; Termine A; Tampellini M; Gorzegno G; Angeli A; Dogliotti L
Ann Oncol; 2001; 12 Suppl 2():S73-7. PubMed ID: 11762356
[TBL] [Abstract][Full Text] [Related]
4. The chromogranins: their roles in secretion from neuroendocrine cells and as markers for neuroendocrine neoplasia.
Feldman SA; Eiden LE
Endocr Pathol; 2003; 14(1):3-23. PubMed ID: 12746559
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of blood chromogranin A measurement in neuroendocrine tumours.
Seregni E; Ferrari L; Bajetta E; Martinetti A; Bombardieri E
Ann Oncol; 2001; 12 Suppl 2():S69-72. PubMed ID: 11762355
[TBL] [Abstract][Full Text] [Related]
6. A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours.
Bernini GP; Moretti A; Ferdeghini M; Ricci S; Letizia C; D'Erasmo E; Argenio GF; Salvetti A
Br J Cancer; 2001 Mar; 84(5):636-42. PubMed ID: 11237384
[TBL] [Abstract][Full Text] [Related]
7. NESP55, a novel chromogranin-like peptide, is expressed in endocrine tumours of the pancreas and adrenal medulla but not in ileal carcinoids.
Jakobsen AM; Ahlman H; Kölby L; Abrahamsson J; Fischer-Colbrie R; Nilsson O
Br J Cancer; 2003 Jun; 88(11):1746-54. PubMed ID: 12771991
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of elevated serum chromogranin A levels.
Syversen U; Ramstad H; Gamme K; Qvigstad G; Falkmer S; Waldum HL
Scand J Gastroenterol; 2004 Oct; 39(10):969-73. PubMed ID: 15513336
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical distribution of chromogranins A and B and secretogranin II in neuroendocrine tumours of the gastrointestinal tract.
Fahrenkamp AG; Wibbeke C; Winde G; Ofner D; Böcker W; Fischer-Colbrie R; Schmid KW
Virchows Arch; 1995; 426(4):361-7. PubMed ID: 7599788
[TBL] [Abstract][Full Text] [Related]
10. Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract.
Schürmann G; Raeth U; Wiedenmann B; Buhr H; Herfarth C
World J Surg; 1992; 16(4):697-701; discussion 701-2. PubMed ID: 1413839
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin a in physiology and oncology.
Louthan O
Folia Biol (Praha); 2011; 57(5):173-81. PubMed ID: 22123459
[TBL] [Abstract][Full Text] [Related]
12. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
Baudin E; Gigliotti A; Ducreux M; Ropers J; Comoy E; Sabourin JC; Bidart JM; Cailleux AF; Bonacci R; Ruffié P; Schlumberger M
Br J Cancer; 1998 Oct; 78(8):1102-7. PubMed ID: 9792158
[TBL] [Abstract][Full Text] [Related]
13. Tumour markers in neuroendocrine tumours.
Oberg K; Janson ET; Eriksson B
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S160-2. PubMed ID: 10604122
[TBL] [Abstract][Full Text] [Related]
14. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
15. Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors.
Tomita T
Bosn J Basic Med Sci; 2020 Aug; 20(3):336-346. PubMed ID: 32020844
[TBL] [Abstract][Full Text] [Related]
16. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of plasma chromogranin A in neuroendocrine tumours.
Tomassetti P; Migliori M; Simoni P; Casadei R; De Iasio R; Corinaldesi R; Gullo L
Eur J Gastroenterol Hepatol; 2001 Jan; 13(1):55-8. PubMed ID: 11204811
[TBL] [Abstract][Full Text] [Related]
18. A comparison between three commercial kits for chromogranin A measurements.
Stridsberg M; Eriksson B; Oberg K; Janson ET
J Endocrinol; 2003 May; 177(2):337-41. PubMed ID: 12740022
[TBL] [Abstract][Full Text] [Related]
19. The biological characteristics of chromogranin A and its role as a circulating marker in neuroendocrine tumours.
Ferrari L; Seregni E; Bajetta E; Martinetti A; Bombardieri E
Anticancer Res; 1999; 19(4C):3415-27. PubMed ID: 10629629
[TBL] [Abstract][Full Text] [Related]
20. Expression of amino acid sequences of the chromogranin A molecule and synaptic vesicle protein 2 in neuroendocrine tumors of the lung.
Portela-Gomes GM; Grimelius L; Stridsberg M; Bresaola E; Viale G; Pelosi G
Virchows Arch; 2005 Jun; 446(6):604-12. PubMed ID: 15906087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]